204 related articles for article (PubMed ID: 24330494)
1. The antiangiogenic activities of ethanolic crude extracts of four Salvia species.
Zihlif M; Afifi F; Abu-Dahab R; Abdul Majid AM; Sumrein H; Saleh MM; Nassar ZD; Naffa R
BMC Complement Altern Med; 2013 Dec; 13():358. PubMed ID: 24330494
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapeutic potentials of the stem bark of Balanite aegyptiaca (L.) Delile: an antiangiogenic, antitumor and antioxidant agent.
Hassan LE; Dahham SS; Saghir SA; Mohammed AM; Eltayeb NM; Majid AM; Majid AS
BMC Complement Altern Med; 2016 Oct; 16(1):396. PubMed ID: 27760539
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis.
Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688
[TBL] [Abstract][Full Text] [Related]
5. Suppression of VEGF-induced angiogenesis and tumor growth by Eugenia jambolana, Musa paradisiaca, and Coccinia indica extracts.
M HR; Ghosh D; Banerjee R; Salimath BP
Pharm Biol; 2017 Dec; 55(1):1489-1499. PubMed ID: 28367666
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer.
Nagaraju GP; Zhu S; Ko JE; Ashritha N; Kandimalla R; Snyder JP; Shoji M; El-Rayes BF
Cancer Lett; 2015 Feb; 357(2):557-65. PubMed ID: 25497868
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenesis and antioxidant activity of ethanol extracts of Pithecellobium jiringa.
Muslim NS; Nassar ZD; Aisha AF; Shafaei A; Idris N; Majid AM; Ismail Z
BMC Complement Altern Med; 2012 Nov; 12():210. PubMed ID: 23126282
[TBL] [Abstract][Full Text] [Related]
8. Water extract of Clinacanthus nutans leaves exhibits in vitro, ex vivo and in vivo anti-angiogenic activities in endothelial cell via suppression of cell proliferation.
Ng CT; Fong LY; Tan JJ; Rajab NF; Abas F; Shaari K; Chan KM; Juliana F; Yong YK
BMC Complement Altern Med; 2018 Jul; 18(1):210. PubMed ID: 29980198
[TBL] [Abstract][Full Text] [Related]
9. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.
Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM
Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
Oh SH; Woo JK; Jin Q; Kang HJ; Jeong JW; Kim KW; Hong WK; Lee HY
Int J Cancer; 2008 Jan; 122(1):5-14. PubMed ID: 17764071
[TBL] [Abstract][Full Text] [Related]
11. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
12. Screening the antiangiogenic activity of medicinal plants grown and sold in Jordan.
Zihlif M; Afifi F; Muhtaseb R; Al-Khatib S; Abaza I; Naffa R
Planta Med; 2012 Feb; 78(3):297-301. PubMed ID: 22174075
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic activity of phthalides-enriched Angelica Sinensis extract by suppressing WSB-1/pVHL/HIF-1α/VEGF signaling in bladder cancer.
Chen MC; Hsu WL; Chang WL; Chou TC
Sci Rep; 2017 Jul; 7(1):5376. PubMed ID: 28710377
[TBL] [Abstract][Full Text] [Related]
14. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
15. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
[TBL] [Abstract][Full Text] [Related]
16. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic effect of Nelumbo nucifera leaf extracts in human umbilical vein endothelial cells with antioxidant potential.
Lee JS; Shukla S; Kim JA; Kim M
PLoS One; 2015; 10(2):e0118552. PubMed ID: 25714482
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic studies of antiproliferative effects of Salvia triloba and Salvia dominica (Lamiaceae) on breast cancer cell lines (MCF7 and T47D).
Abu-Dahab R; Abdallah MR; Kasabri V; Mhaidat NM; Afifi FU
Z Naturforsch C J Biosci; 2014; 69(11-12):443-51. PubMed ID: 25854764
[TBL] [Abstract][Full Text] [Related]
19. Piceatannol-3-O-β-D-glucopyranoside (PG) exhibits in vitro anti-metastatic and anti-angiogenic activities in HT1080 malignant fibrosarcoma cells.
Kim A; Ma JY
Phytomedicine; 2019 Apr; 57():95-104. PubMed ID: 30668328
[TBL] [Abstract][Full Text] [Related]
20. Bp5250 inhibits vascular endothelial growth factor-induced angiogenesis and HIF-1α expression on endothelial cells.
Lin KT; Lien JC; Chung CH; Kuo SC; Huang TF
Naunyn Schmiedebergs Arch Pharmacol; 2012 Jan; 385(1):39-49. PubMed ID: 21947252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
